ESTRO 2024 - Abstract Book

S1881

Clinical - Mixed sites, palliation

ESTRO 2024

1. Dalsania RM, Shah KP, Stotsky-Himelfarb E, Hoffe S, Willingham FF. Management of Long-Term Toxicity From Pelvic Radiation Therapy. American Society of Clinical Oncology Educational Book. 2021; 41: 147-157. https://ascopubs.org/doi/full/10.1200/EDBK_323525

2. Pelvic Radiation Disease Association. Pelvic radiation disease in the UK. https://www.prda.org.uk/information health-professionals/ [Accessed 16th July 2023]

3. Huh JW, Tanksley J, Chino J, Willet CG, Dewhirst MW. Long-term Consequences of Pelvic Irradiation: Toxicities, Challenges, and Therapeutic Opportunities with Pharmacologic Mitigators. Clinical Cancer Research. 2020; 26(13):3079-3090. https://aacrjournals.org/clincancerres/article/26/13/3079/82622/Long-term-Consequences-of Pelvic-Irradiation

1048

Proffered Paper

Cardiac SABR for Ventricular Tachycardia – UK experience of safety and efficacy

Shahreen Ahmad 1 , John Whitaker 2 , Matthew G Bates 3 , Justin Lee 4 , Stephen Riley 5 , Chris Dean 6 , Anish Bhuva 7 , Georgios Ntentas 8 , Marina Khan 9 , P N Plowman 10 , Mehul Dhinoja 7 , Caroline Sisodia 9 , Jim Daniel 11 , Rebecca Preston 12 , Ewen Shepherd 13 , Philip Atherton 14 , Nicholas F Kelland 4 , Christopher A Rinaldi 2 , Clive Peedel 15 , Matthew Q Hatton 16 1 Guy's & St Thomas' NHS Foundation Trust, Clinical Oncology, London, United Kingdom. 2 Guy's & St Thomas' NHS Foundation Trust, Cardiology, London, United Kingdom. 3 South Tees Hospitals NHS Foundation Trust, Cardiology, Middlesborough, United Kingdom. 4 Sheffield Teaching Hospitals NHS Foundation Trust, Cardiology, Sheffield, United Kingdom. 5 Sheffield Teaching Hospitals NHS Foundation Trust, Medical Physics, Sheffield, United Kingdom. 6 Barts and the London NHS Trust, Medical Physics, London, United Kingdom. 7 Barts and the London NHS Trust, Cardiology, London, United Kingdom. 8 Guy's & St Thomas' NHS Foundation Trust, Medical Physics, London, United Kingdom. 9 Guy's & St Thomas' NHS Foundation Trust, Radiotherapy, London, United Kingdom. 10 Barts and the London NHS Trust, Clinical Oncology, London, United Kingdom. 11 South Tees Hospitals NHS Foundation Trust, Medical Physics, Middlesborough, United Kingdom. 12 Guy's & St Thomas' NHS Foundation Trust, Radiology, London, United Kingdom. 13 Newcastle upon Tyne Hospitals NHS Foundation Trust, Cardiology, Newcastle, United Kingdom. 14 Newcastle upon Tyne Hospitals NHS Foundation Trust, Clinical Oncology, Newcastle, United Kingdom. 15 South Tees Hospitals NHS Foundation Trust, Clinical Oncology, Middlesborough, United Kingdom. 16 Sheffield Teaching Hospitals NHS Foundation Trust, Clinical Oncology, Sheffield, United Kingdom

Purpose/Objective:

Ventricular tachycardia (VT) is a potentially life-threatening condition, for which standard treatments include implantable cardioverter defibrillator (ICD) implantation, anti-arrhythmic drugs (AAD) and catheter ablation (CA). In situations where AAD and CA are contra-indicated or have failed to control VT, cardiac stereotactic ablative radiotherapy (cSABR) is a new treatment strategy that is showing promising early results. Through the UK SABR Consortium Cardiac Subgroup five hospitals have started cSABR programmes and we report safety and outcomes from all patients treated in the UK.